胡屹

传染病流行病学、组学分子流行病学、人群药理学和公共卫生服务体系等方面的研究

《分子流行病学》、《流行病学基础》、《公共卫生生物信息学导论》等

中国防痨协会第十一届结核病感染控制专业分会委员

中国防痨协会第十一届青年理事会委员

上海市医学会结核病学专科分会第三届委员会青年委员会委员

中华预防医学科技二等奖

上海市科技进步三等奖

上海市医学奖二等奖

1. Davies Forsman L, Niward K, Kuhlin J, Zheng X, Zheng R, Ke R, … Hu Y(通讯作者). Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China. Eur Respir J. 2021;57(3). Epub 2020/11/07. doi: 10.1183/13993003.03463-2020. PubMed PMID: 33154028.
2. Wu Q, Liu J, Wang Y, Zhou Q, Wang X, Xuan Z, … Hu Y(通讯作者). Effectiveness of second-dose varicella vaccination as post-exposure prophylaxis: a prospective cohort study. Clin Microbiol Infect. 2019;25(7):872-7. Epub 2018/11/26. doi: 10.1016/j.cmi.2018.11.013. PubMed PMID: 30472425.
3. Zheng X, Bao Z, Forsman LD, Hu Y（通讯作者）, Ren W, Gao Y, et al. Drug exposure and minimum inhibitory concentration predict pulmonary tuberculosis treatment response. Clin Infect Dis. 2020. Epub 2020/10/19. doi: 10.1093/cid/ciaa1569. PubMed PMID: 33070176.
4. Wu Q, Zaid M, Xuan Z, Wang C, Gu H, Shi M, …Hu Y(通讯作者) Changes in epidemiological features of vaccine preventable infectious diseases among three eras of national vaccination strategies from 1953 to 2018 in Shanghai, China. Lancet Reg Health West Pac. 2021;7:100092. Epub 2021/07/31. doi: 10.1016/j.lanwpc.2021.100092. PubMed PMID: 34327419; PubMed Central PMCID: PMCPMC8315356.
5. Hu Y, Zheng X, Davies Forsman L, Ning Z, Chen C, Gao Y, et al. Emergence of additional drug resistance during treatment of multidrug-resistant tuberculosis in China: a prospective cohort study. Clin Microbiol Infect. 2021. Epub 2021/04/26. doi: 10.1016/j.cmi.2021.04.001. PubMed PMID: 33895338.

      先后牵头承担了国家自然科学基金面上项目、上海市卫计委、WHO-TDR项目，作为子任务负责人承担了“十三五”、“十二五”国家科技重大专项课题各1项，参加实施了国家“十一五”国家科技重大专项2项、863课题、欧盟第七框架和上海市科委基础重点课题等多个国内外重要科研项目。